Covid 19 coronavirus: Scientists alarmed at spread of Covid mutant
20 Dec, 2020 06:28 PM
4 minutes to read
Financial Times
By: Clive Cookson
New strain of virus is 70 per cent more transmissible but seemingly no more deadly after its detection in UK and elsewhere. The highly infectious variant of coronavirus that has emerged in south-east England is spreading rapidly to the rest of the UK and is already present elsewhere in the world, scientists warned on Sunday.
The World Health Organisation said its Evolution Working Group is working closely with the UK medical authorities to understand how the variant, now called B.1.1.7, is likely to affect the course of the pandemic. It has been detected in the Netherlands, Denmark and Australia.
B 1 1 7: Was Experten bislang zu den Folgen der neuen Corona-Variante sagen welt.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from welt.de Daily Mail and Mail on Sunday newspapers.
Posted on 418
Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced plans to host a virtual event and live Q&A session on Tuesday, January 19, 2021 at 8:00 am ET.
Leading researchers and clinicians, along with Company executives, will discuss current interventions for the treatment of acquired sensorineural hearing loss (SNHL), unmet medical needs for hearing loss patients and the potential of FX-322 to transform the current standard of care.
Presenters to include:
Robert S. Langer, Sc.D., Scientific Co-Founder; Member of Frequency’s Board of Directors; David H. Koch Institute Professor, Massachusetts Institute of Technology
Print
Lorilei Lebruska was raised on a Nebraska family farm. At 18, she joined the Army in 1988 and several years later was deployed to war in the Middle East.
During her year at war Lebruska was on the front lines assigned to an intelligence unit searching for enemy locations to coordinate artillery strikes. Her unit traveled close to the enemy and took constant missile fire.
After an ammunition depot was bombed near Lebruska’s location she began feeling disoriented numbness, fatigue, vertigo and loss of balance. Her memory and thinking were fogged.
Eventually, she was diagnosed with PTSD and nerve gas-induced multiple sclerosis (MS) with resulting brain damage.
Laura McKnight
Jeff McKnight, a molecular biologist at the University of Oregon, died in October at the age of 36.
McKnight’s research focused on chromatin, a complex of DNA and proteins that controls when and how DNA can be accessed for replication and gene expression. He was one of the earliest researchers in the world capable of directly manipulating its structure, stemming back to his postdoctoral work at the Fred Hutchinson Cancer Research Center using the model organism
Saccharomyces cerevisiae. When he had started his own lab in 2016, McKnight said at the time that his “real dream” was to apply his work to the dozens of human diseases that involve some level of chromatin disruption, including Parkinson’s, Alzheimer’s, and Huntington’s.